Aortic Aneurysm, Abdominal Clinical Trial
— FIH-NZOfficial title:
Aorfix™ Generation IV Delivery System "IntelliFlex™" Study
Verified date | October 2021 |
Source | Lombard Medical |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational [Patient Registry] |
The First In Human (FIH) study is a long-term, single center, non-randomized study established by Lombard Medical, Inc. to collect "on-label" data in the clinical setting on patients undergoing endovascular repair with IntelliFlex™, the latest generation of the Aorfix™ AAA Flexible Stent Graft Delivery System, for treatment of abdominal aortic and aorto-iliac aneurysms in anatomy where the aorta in the aneurysm neck is bent through an angle between 0° and 90°.
Status | Active, not recruiting |
Enrollment | 10 |
Est. completion date | November 2021 |
Est. primary completion date | November 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 21 Years and older |
Eligibility | Inclusion Criteria: 1. Diagnosed abdominal aortic aneurysm with indication for endovascular repair. 2. Intention to electively implant the Aorfix™ Stent Graft System with IntelliFlex™ Delivery Device. Exclusion Criteria: 1. Do not comply with the indications for Aorfix™ in the IFU. 2. Unwillingness or inability to comply with the recommended follow-up assessments according to the standards of care of the investigative site. 3. Unwillingness or inability to provide informed consent to both the study and the EVAR procedure. 4. Patients in whom Aorfix™ is being placed as a secondary procedure to a previous surgical or endovascular treatment of an AAA other than with another Aorfix™ graft. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Lombard Medical |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of participants with Successful Implant Delivery (30d) | Successful implant delivery is also called Primary Technical Success, defined as successful introduction and deployment of the device in the absence of surgical conversion or mortality, Type I or III endoleaks, or graft limb obstruction.
The numbers of participants having Primary Technical Success on completion of the index procedure and Clinical Success 12 months after the procedure will be recorded. |
1 Month | |
Primary | Number of participants with Treatment Success (1year) | Treatment success, or Clinical Success, requires successful deployment of the endovascular device at the intended location without death as a result of aneurysm-related treatment, Type I or III endoleak, graft infection or thrombosis, aneurysm expansion (diameter >=5 mm, or volume >=5%), aneurysm rupture, or conversion to open repair.
The numbers of participants having Primary Technical Success on completion of the index procedure and Clinical Success 12 months after the procedure will be recorded. |
12 Months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03657979 -
TAP-Block in Abdominal Aortic Surgery
|
Phase 4 | |
Enrolling by invitation |
NCT01465425 -
Extracolonic Findings on Computed Tomography (CT) Colonography
|
||
Completed |
NCT02845167 -
Effect of Preoperative Exercise on Postoperative Outcome in AAA Patients: Pilot Study
|
N/A | |
Not yet recruiting |
NCT00358085 -
NExT ERA: National Expertise Based Trial of Elective Repair of Abdominal Aortic Aneurysms: A Pilot Study
|
Phase 3 | |
Terminated |
NCT00118573 -
Comparison of Surveillance Versus Aortic Endografting for Small Aneurysm Repair
|
Phase 4 | |
Completed |
NCT04792411 -
Adherence and Acceptability of a Remote, Home-based, Pre-surgery Programme for Patients Undergoing Abdominal Aortic Aneurysm Surgery
|
N/A | |
Completed |
NCT04930172 -
TOtal tRansfemoral branCHed endovasCular tHoracoabdominal Aortic Repair Registry
|
||
Withdrawn |
NCT02995642 -
Targeted PET/CT and PET/MRI Imaging of Vascular Inflammation
|
Phase 2 | |
Completed |
NCT01980901 -
Post-Approval Study of the Ovation™/Ovation Prime™ Abdominal Stent Graft System
|
||
Active, not recruiting |
NCT01698671 -
InterGard Synergy Post-Marketing Surveillance Study
|
N/A | |
Enrolling by invitation |
NCT00831870 -
EndoSure Sensor for Long-term Follow-up After Endovascular AAA Repair
|
N/A | |
Recruiting |
NCT05972018 -
Liposomal Bupivacaine/Bupivacaine in RS Blocks vs. Ropivacaine in RS Blocks And Catheters
|
Phase 4 | |
Not yet recruiting |
NCT02997618 -
The AAA Get Fit Trial: A Pilot Randomised Controlled Trial of Community Based Exercise in Patients With Abdominal Aortic Aneurysms
|
N/A | |
Completed |
NCT00349947 -
Exercise Therapy to Treat Adults With Abdominal Aortic Aneurysms
|
Phase 1 | |
Completed |
NCT04080557 -
Abdominal Aortic Aneurysm Patients Remain at Risk for Delirium on the Surgical Ward After Intensive Care Unit Dismissal
|
||
Recruiting |
NCT05484115 -
Comparison of EVAR and ESAR for Infrarenal Aortic Aneurysms With a Wide Proximal Neck
|
N/A | |
Recruiting |
NCT04503395 -
ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES
|
N/A | |
Completed |
NCT02867501 -
Venous Distension in Patients With Aneurysmatic Arterial Disease
|
N/A | |
Recruiting |
NCT02345590 -
Eplerenone in the Management of Abdominal Aortic Aneurysms
|
Phase 4 | |
Recruiting |
NCT01985906 -
Safety and Efficacy of Multiple Overlapping Uncovered Stents for Pararenal Aortic Aneurysm Repair
|
N/A |